Magnitude of Problem
Globally, is about 30 %
In developing countries & India,
incidence is around
40
90%.
Responsible for 40% of maternal
deaths in third world countries.
Important cause of direct and
indirect maternal deaths
Symptoms
Irritability
Lack of
Concentration
Fatigue
Infection
Palpitatio
n
Weakness
Dizziness
Clinical Features
Pallor of skin
And m/m
Soft ejection
systolic
murmur
Edema
Signs
Platynychia
Platynychia
Koilonychia
Koilonychia
Tachycardia
Glossitis
Stomatitis
Causes of Anaemia
Physiological
Pathological
Nutritional
Haemorrhagic
Haemolytic
Iron Requirement
Iron Absorption
1
Amount of iron in the
body
Skin
Iron Loss
Urine
1-2mg/d
Feces
Menstruation
20-30mg/c
TOTAL
800 1000
mg
20 to 32
weeks
6.8 mg / day
5.5 mg / day
2.5 mg / day
RBC
=500mg
Fetus+Placenta
=450mg
Third stage blood loss
=200mg
Total
=
Normal Levels
Hb
13.5 14 gm %
R.B.C.
Serum Iron
50 150 g / dL
TIBC
300 360 g / dL
Transferrin saturation
25 50 %
S. Ferritin level
30 g / Lit
30 g / dL
Erythropoietin
15.20 U / Lit
MCV
76 100 fL
MCH
27 33 pg
MCHC
33.37 gm / dL
PCV
32 40 %
Thalassemia
Chronic Diseases
Serum Iron
Decreased
Normal / Increased
Decreased
TIBC
Increased
Normal
Decreased or N
Transferrin
Decreased
N or Increased
N or Decreased
Serum Ferritin
Decreased
N or Increased
Marrow Iron
Decreased /
absent
N or Increased
No rise in Hb
No rise
Saturation
Nutritional Anaemia :
Major Health Problems
National Nutrition Anaemia Prophylaxis
Programme (NNAPP 1971 - 72)
Pregnancy
FS + FA
Lactating mothers
Family planning acceptors
Children 1 to 11 years
Chronic malnutrition
Complications - Pregnancy
IUGR
IUD
CCF
PIH
INFECTION
Medical
Disorder
PRETERM
LABOUR
IUH
Complications - Labour
PPH
Instrumental
delivery
MATERNAL
PERINATAL
CCF
Foetal
Distress
Morbidity
Mortality
Management Options
Pre pregnancy :
Modalities of Management
Oral
Iron
Parenteral
Injectable Iron
Blood
transfusion
Human Recombinant
Erythropoietin
Oral Iron
100 mg elemental Iron ------- 0.18 gm % day
-ve
Phosphate
phytate
Iron absorption
-ve
Bioavailability
of Iron
Iron stores poor
-ve
Worm
infestation
Borbolla JR. Cicero RE, Dibilox MM, Sotres RD et al.. Rev Mex Pediatr 2000; 67(2): 63-67
Heubers KA, Brittenham GM, Csiba E, Finch CA. J Lab Clin Med 1986 ; 108 ; 473-8.
Parenteral Therapy
I.V.
I.M.
100 mg
elemental Iron
Anaphylactic
reaction
Anaphylactic
reaction
Fractionated Irondextran
[Iron hydroxide dextran
complex]
Les
s
Les
s
Hb 0.21 gm %
Parenteral Therapy :
Traditional Indications
Gastrointestinal disorders
Malabsorption syndromes